EON Network October Newsletter |
Welcome to the first edition of the Exercise Oncology/Oncology Nutrition (EON) Network newsletter. We are excited to welcome you to this network for exercise oncology and oncology nutrition researchers, clinicians, and others, who all share the common goal of using diet and physical activity to improve cancer treatment outcomes.
Monthly newsletters will now be delivered straight to your inbox and you can visit the EON Network webpage at any time to find upcoming webinars, updates on exercise oncology/oncology nutrition-related events, publications, and resources.
To submit your news, events, or publications for the next EON Network Newsletter, click the button below and send us an email!
|
|
|
The quarterly EON Webinar Series will kick off in October 2023 and include topics in the fields of exercise oncology and oncology nutrition. The webinars will be recorded and archived on the EON Network webpage.
|
|
|
|
Impact of Exercise and Nutrition on Cancer Treatment-Related Outcomes: What’s been examined and what’s yet to be examined
Melinda Irwin, PhD, MPH
This webinar will present LEANer (Lifestyle, Exercise And Nutrition) findings to evaluate if an exercise and nutrition program improves chemotherapy and endocrine therapy completion rates. Gaps in the literature will also be discussed.
|
|
|
December 13, 2-3 PM ET
Challenges and Considerations in the Design and Analyses of Randomized trials of Exercise and Chemotoxicity | Bette Caan, DrPH and Alexandra Binder, ScD – Register
|
February 15, 2-3 PM ET
Role of nutrition in improving cancer treatment outcomes: evidence, challenges, and future directions | Kim Robien, PhD, RD, CSO, FAND
|
April 10, 2-3 PM ET
Optimizing Monitoring and Reporting of Exercise Training Dose, Adherence, and Safety | Jessica Scott, PhD – Register
|
|
|
The LEANer Study led by Melinda Irwin, PhD, MPH finds a targeted diet and exercise intervention may improve outcomes for women undergoing chemotherapy for breast cancer. |
Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li FY, Ferrucci LM, Puklin L, Cao A, Nguyen TH, Neuhouser ML, Hershman DL, Basen-Engquist K, Jones BA, Knobf T, Chagpar AB, Silber A, Tanasijevic A, Ligibel JA, Irwin ML. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. J Clin Oncol. 2023 Sep 1. PMID: 37656930.
|
Other Publications from ENICTO Collaborators |
|
|
Cao A, Cartmel B, Li FY, Gottlieb LT, Harrigan M, Ligibel JA, Gogoi R, Schwartz PE, Esserman DA, Irwin ML, Ferrucci LM. Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023 Aug 1;6(8). PMID: 37526937. Read here.
Cheng E, Caan BJ, Cawthon PM, Evans WJ, Hellerstein MK, Shankaran M, Nyangau E, Campbell KL, Lee C, Binder AM, Meyerhardt JA, Schmitz KH, Cespedes Feliciano EM. Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer. Cancer Epidemiol Biomarkers Prev. 2023 Jul 14. PMID: 37450841. Read here.
Caru M, Wurz A, Brunet J, Barb ED, Adams SC, Roth ME, Winters-Stone K, Fidler-Benaoudia MM, Dandekar S, Ness KK, Culos-Reed SN, Schulte F, Rao P, Mizrahi D, Swartz MC, Smith M, Valle CG, Kadan-Lottick NS, Dieli-Conwright CM, Schmitz KH; North American Consortium on Exercise in AYAs Diagnosed with Cancer. Physical activity and physical fitness assessments in adolescents and young adults diagnosed with cancer: a scoping review. Support Care Cancer. 2023 Sep 11;31(10):569. PMID: 37695526. Read here.
|
|
Lavery JA, Boutros PC, Scott JM, Tammela T, Moskowitz CS, Jones LW. Pan-Cancer Analysis of Postdiagnosis Exercise and Mortality. J Clin Oncol. 2023 Aug 31. PMID: 37651670. Read here.
Kennedy MA, Potiaumpai M, Maitin-Shepard M, Wilson CM, Campbell A, Schwartz AL, Gorzelitz J, Caru M, Grimmett C, Schmitz KH. Looking back: a review of policy implications for exercise oncology. J Natl Cancer Inst Monogr. 2023(61):140-148. PMID: 37139975. Read here.
Shah UA, Ballinger TJ, Bhandari R, Dieli-Cornwright CM, Guertin KA, Hibler EA, Kalam F, Lohmann AE, Ippolito JE. Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges. J Natl Cancer Inst Monogr. 2023(61):56-57. PMID: 37139984. Read here.
Purcell SA, Kok DE, Ketterl T, Garcia MB, Joffe L, Brown JC, Dieli-Conwright CM, Williams GR. Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition. J Natl Cancer Inst Monogr. 2023(61):3-11. PMID: 37139976. Read here.
|
|
|
Do you have news, an event, or a publication you would like to see included in the next edition of the EON Network Newsletter? We invite any updates from the EON Network and encourage you to send information that may be of interest to eonnetwork@bsc.gwu.edu.
|
|
|
|
- November 14, 2023 (Virtual)
-
Dual foci on cancer and diabetes at the interfaces of overweight, obesity, carcinogenesis, diabetogenesis and complications of treatments
- Deadline for abstracts is October 13, 2023
|
|
|
|
- June 27-29, 2024 in Lille, France
- Theme: Empower People Impacted by Cancer and Living with Toxicities
- Deadline for abstracts is December 20, 2023
|
|
|
Polen-De C, Giri S, Fadadu P, Weaver A, Mcgree ME, Moynagh M, Takahashi N, Jatoi A, Lebrasseur NK, Cliby W, Williams G, Kumar A. Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer. J Natl Cancer Inst Monogr. 2023(61):43-48. PMID: 37139982. Read here.
Arteaga DP, DeKraker C, Ennis M, Dewey N, Goebel EA, Welch S, Pimentel I, Ippolito JE, Lohmann AE. Body composition and endometrial cancer outcomes. J Natl Cancer Inst Monogr. 2023(61):49-55. PMID: 37139979. Read here.
Kalam F, James DL, Li YR, Coleman MF, Kiesel VA, Cespedes Feliciano EM, Hursting SD, Sears DD, Kleckner AS. Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes. J Natl Cancer Inst Monogr. 2023(61):84-103. PMID: 37139971. Read here.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6110 Executive Blvd Suite 750 | Rockville, MD 20852 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|